Cross-sectional associations of different types of nature exposure with psychotropic, antihypertensive and asthma medication.
Cross-Sectional Studies
Environment
Epidemiology
Public health
Journal
Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
24
05
2022
accepted:
05
12
2022
pubmed:
17
1
2023
medline:
21
1
2023
entrez:
16
1
2023
Statut:
ppublish
Résumé
Exposure to natural environments is thought to be beneficial for human health, but the evidence is inconsistent. To examine whether exposure to green and blue spaces in urban environments is associated with mental and physical health in Finland. The Helsinki Capital Region Environmental Health Survey was conducted in 2015-2016 in Helsinki, Espoo and Vantaa in Finland (n=7321). Cross-sectional associations of the amounts of residential green and blue spaces within 1 km radius around the respondent's home (based on the Urban Atlas 2012), green and blue views from home and green space visits with self-reported use of psychotropic (anxiolytics, hypnotics and antidepressants), antihypertensive and asthma medication were examined using logistic regression models. Indicators of health behaviour, traffic-related outdoor air pollution and noise and socioeconomic status (SES) were used as covariates, the last of these also as a potential effect modifier. Amounts of residential green and blue spaces or green and blue views from home were not associated with medications. However, the frequency of green space visits was associated with lower odds of using psychotropic medication (OR=0.67, 95% CI 0.55 to 0.82 for 3-4 times/week; 0.78, 0.63 to 0.96 for ≥5 times/week) and antihypertensive (0.64, 0.52 to 0.78; 0.59, 0.48 to 0.74, respectively) and asthma (0.74, 0.58 to 0.94; 0.76, 0.59 to 0.99, respectively) medication use. The observed associations were attenuated by body mass index, but no consistent interactions with SES indicators were observed. Frequent green space visits, but not the amounts of residential green or blue spaces, or green and blue views from home, were associated with less frequent use of psychotropic, antihypertensive and asthma medication in urban environments.
Sections du résumé
BACKGROUND
Exposure to natural environments is thought to be beneficial for human health, but the evidence is inconsistent.
OBJECTIVE
To examine whether exposure to green and blue spaces in urban environments is associated with mental and physical health in Finland.
METHODS
The Helsinki Capital Region Environmental Health Survey was conducted in 2015-2016 in Helsinki, Espoo and Vantaa in Finland (n=7321). Cross-sectional associations of the amounts of residential green and blue spaces within 1 km radius around the respondent's home (based on the Urban Atlas 2012), green and blue views from home and green space visits with self-reported use of psychotropic (anxiolytics, hypnotics and antidepressants), antihypertensive and asthma medication were examined using logistic regression models. Indicators of health behaviour, traffic-related outdoor air pollution and noise and socioeconomic status (SES) were used as covariates, the last of these also as a potential effect modifier.
RESULTS
Amounts of residential green and blue spaces or green and blue views from home were not associated with medications. However, the frequency of green space visits was associated with lower odds of using psychotropic medication (OR=0.67, 95% CI 0.55 to 0.82 for 3-4 times/week; 0.78, 0.63 to 0.96 for ≥5 times/week) and antihypertensive (0.64, 0.52 to 0.78; 0.59, 0.48 to 0.74, respectively) and asthma (0.74, 0.58 to 0.94; 0.76, 0.59 to 0.99, respectively) medication use. The observed associations were attenuated by body mass index, but no consistent interactions with SES indicators were observed.
CONCLUSIONS
Frequent green space visits, but not the amounts of residential green or blue spaces, or green and blue views from home, were associated with less frequent use of psychotropic, antihypertensive and asthma medication in urban environments.
Identifiants
pubmed: 36646464
pii: oemed-2022-108491
doi: 10.1136/oemed-2022-108491
pmc: PMC9887361
doi:
Substances chimiques
Antihypertensive Agents
0
Psychotropic Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111-118Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Int J Environ Res Public Health. 2018 Mar 03;15(3):
pubmed: 29510520
Int J Environ Res Public Health. 2021 May 29;18(11):
pubmed: 34072529
J Epidemiol Community Health. 2021 May;75(5):470-476
pubmed: 33500323
Annu Rev Public Health. 2014;35:207-28
pubmed: 24387090
Sci Rep. 2020 Nov 6;10(1):19408
pubmed: 33159132
Int J Environ Res Public Health. 2020 Sep 25;17(19):
pubmed: 32992786
Int J Environ Res Public Health. 2021 May 12;18(10):
pubmed: 34066187
Int J Environ Res Public Health. 2021 Apr 13;18(8):
pubmed: 33924490
Health Place. 2019 Jan;55:20-28
pubmed: 30459052
Int J Environ Res Public Health. 2021 Mar 04;18(5):
pubmed: 33806546
Environ Res. 2018 Oct;166:628-637
pubmed: 29982151
Environ Int. 2019 Oct;131:105016
pubmed: 31352260
PLoS One. 2020 Nov 30;15(11):e0242815
pubmed: 33253308
PLoS One. 2018 Sep 12;13(9):e0203000
pubmed: 30208073
Environ Int. 2020 Dec;145:106138
pubmed: 32961469
Int J Environ Res Public Health. 2021 Oct 20;18(21):
pubmed: 34769549
Health Place. 2022 Mar;74:102760
pubmed: 35134742
Annu Rev Public Health. 2021 Apr 1;42:317-328
pubmed: 33317317
Environ Res. 2020 Dec;191:110032
pubmed: 32814106
Int J Environ Res Public Health. 2020 Jan 22;17(3):
pubmed: 31979152
Int J Environ Res Public Health. 2021 Aug 26;18(17):
pubmed: 34501598
J Allergy Clin Immunol. 2018 Apr;141(4):1169-1179
pubmed: 29627041
Environ Res. 2018 Jan;160:531-540
pubmed: 29106952
Health Place. 2019 Jan;55:59-70
pubmed: 30502229
Environ Health Perspect. 2014 Dec;122(12):1329-35
pubmed: 25157960
BMJ Open. 2020 Aug 16;10(8):e038673
pubmed: 32801206
Environ Res. 2020 Oct;189:109914
pubmed: 32980008
Environ Res. 2018 Apr;162:231-239
pubmed: 29358115
Epidemiology. 2017 Jan;28(1):63-71
pubmed: 27525811
BMC Public Health. 2017 Mar 23;17(1):276
pubmed: 28330465
Curr Environ Health Rep. 2018 Mar;5(1):77-87
pubmed: 29392643
Sci Rep. 2021 Apr 26;11(1):8903
pubmed: 33903601
Int J Environ Res Public Health. 2021 Apr 30;18(9):
pubmed: 33946197
Int J Hyg Environ Health. 2017 Nov;220(8):1207-1221
pubmed: 28843736
Environ Res. 2017 Oct;158:301-317
pubmed: 28672128
Health Place. 2017 May;45:77-84
pubmed: 28319857
Environ Int. 2018 Oct;119:287-294
pubmed: 29990948
Int J Health Geogr. 2017 Apr 26;16(1):16
pubmed: 28446187
Environ Pollut. 2022 May 15;301:118990
pubmed: 35181451